Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: a pragmatic fast-track randomised controlled trial (BreathEase)

Conclusions These findings demonstrate positive effects of the MBS in reducing burden caused by chronic breathlessness in advanced illness across a wide range of patients. Further evaluation in subgroups of patients and with a longitudinal perspective is needed.

http://erj.ersjournals.com/cgi/content/short/58/2/2002139?rss=1

Source: European Respiratory Journal - August 26, 2021 Category: Respiratory Medicine Authors: Schunk, M., Le, L., Syunyaeva, Z., Haberland, B., Tänzler, S., Mansmann, U., Schwarzkopf, L., Seidl, H., Streitwieser, S., Hofmann, M., Müller, T., Weiss, T., Morawietz, P., Rehfuess, E. A., Huber, R. M., Berger, U., Bausewein, C. Tags: Respiratory clinical practice Original Articles: Breathlessness Source Type: research